Q4 2025 · 13F-HR
Tetragon Partners GP Ltdholdings as filed
Filed 2026-02-17 · accession 0000902664-26-001035
$474.3M
Reported value
28
Positions
2025-12-31
Period end
The Brief · Tetragon Partners GP Ltd · Q4 2025
AI · grounded in 13F
Tetragon Partners GP Ltd closed its position in [[stock:BABA 0.5 06/01/31]], reducing exposure by $174.8M. The fund also exited positions in HYG and [[stock:LARCN 1.75 01/15/27]], which decreased holdings by $64.9M and $24.6M respectively. On the buy side, the fund established new positions in PRAX for $6.8M, RAPT for $4.5M, and AGIO for $4.4M. Additionally, it increased its stake in ARWR by 18.4%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 90364P105 | PATH | UIPATH INC | $286.0M | 60.3% | 17,450,000 | Common | SHARED |
| 50043K406 | KGEI | KOLIBRI GLOBAL ENERGY INC | $27.3M | 5.75% | 6,934,504 | Common | SHARED |
| 55087P104 | LYFT | LYFT INC | $19.4M | 4.08% | 1,000,000 | Common | SHARED |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $18.9M | 3.99% | 9,500,000 | Common | SHARED |
| 85208T107 | CXM | SPRINKLR INC | $17.1M | 3.61% | 2,200,000 | Common | SHARED |
| 98139A105 | WK | WORKIVA INC | $12.9M | 2.73% | 150,000 | Common | SHARED |
| 03589W102 | ANNX | ANNEXON INC | $10.2M | 2.15% | 2,032,455 | Common | SHARED |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $6.8M | 1.43% | 22,952 | Common | SHARED |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $6.6M | 1.40% | 243,800 | Common | SHARED |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $6.4M | 1.36% | 96,935 | Common | SHARED |
| N69605108 | PHVS | PHARVARIS N V | $5.4M | 1.14% | 194,612 | Common | SHARED |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $4.9M | 1.04% | 26,934 | Common | SHARED |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $4.9M | 1.02% | 247,997 | Common | SHARED |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $4.5M | 0.95% | 143,327 | Common | SHARED |
| 75382E208 | RAPT | RAPT THERAPEUTICS INC | $4.5M | 0.94% | 131,770 | Common | SHARED |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $4.4M | 0.93% | 162,018 | Common | SHARED |
| 45258J102 | IMVT | IMMUNOVANT INC | $4.2M | 0.89% | 166,187 | Common | SHARED |
| G01767105 | ALKS | ALKERMES PLC | $3.9M | 0.83% | 141,172 | Common | SHARED |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $3.7M | 0.78% | 260,771 | Common | SHARED |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $3.3M | 0.69% | 272,828 | Common | SHARED |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $3.1M | 0.65% | 82,824 | Common | SHARED |
| 640268306 | NKTR | NEKTAR THERAPEUTICS | $2.9M | 0.62% | 69,287 | Common | SHARED |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $2.9M | 0.61% | 11,814 | Common | SHARED |
| 56565P103 | MPLT | MAPLIGHT THERAPEUTICS INC | $2.9M | 0.61% | 164,525 | Common | SHARED |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $2.2M | 0.47% | 365,369 | Common | SHARED |
| 833445109 | SNOW | SNOWFLAKE INC | $2.2M | 0.46% | 10,000 | Common | SHARED |
| 488445206 | ZVRA | ZEVRA THERAPEUTICS INC | $1.7M | 0.36% | 192,518 | Common | SHARED |
| G29687103 | AVDL | AVADEL PHARMACEUTICALS PLC | $943,093 | 0.20% | 43,763 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.